DigiPath Creates Tier 1 Telecom Network for Digital Pathology

Share Article

DigiPath, Inc® creates PathCloud™, a tier 1 telecom network exclusively for digital pathology. PathCloud’s network is engineered and optimized for highest digital pathology performance and reliability.

DigiPath, Inc®, a provider of affordable, innovative, and reliable digital pathology solutions, creates PathCloud™, a tier 1 telecom network exclusively for digital pathology. PathCloud’s network is engineered and optimized for highest digital pathology performance and reliability. PathCloud is as low as 25 cents per slide per year.

PathCloud supports all generally available viewing software applications and slide scanning hardware manufacturers. PathCloud provides access to store, view, and share digital slides. PathCloud deployment options include end to end data services, and on site configuration servicers. Additionally, PathCloud provides service level agreements on its robust and high capacity network.

Third party image analysis, application, and viewing software developers are invited to join PathCloud to provide reliable and seamless access to national digital pathology network. Additionally, PathCloud will provide a means to support open source software initiatives and deliver these affordable applications to a national digipath pathology network.

“DigiPath’s team built telecom networks which supported over 35,000 locations throughout the country,“ stated Eric Stoppenhagen, CEO of DigiPath. “DigiPath brings this IT experience to PathCloud™, the first and only telecom network optimized for digital pathology.”

See http://www.digipath.biz/Services.html for further technical specifications.

About DigiPath, Inc.
DigiPath, Inc. provides the next generation of affordable, innovative, and reliable digital pathology solutions. DigiPath’s advisors bring over 60 years combined expertise in pioneering digital pathology, implementing over 500 installations at community pathology practices, hospitals, academic medical centers, reference laboratories, biopharma organizations, and life science research institutions worldwide.

SAFE HARBOR STATEMENT
This Press Release may contain certain forward-looking statements within the meaning of the Securities Litigation Reform Act of 1995. DigiPath has tried, whenever possible, to identify these forward-looking statements using words such as "anticipates," "believes," "estimates," "expects," "plans," "intends," "potential" and similar expressions. These statements reflect DigiPath's current beliefs and are based upon information currently available to it. Accordingly, such forward-looking statements involve known and unknown risks, uncertainties and other factors which could cause DigiPath's actual results, performance or achievements to differ materially from those expressed in or implied by such statements. DigiPath undertakes no obligation to update or provide advice in the event of any change, addition or alteration to the information catered in this Press Release including such forward-looking statements.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

DigiPath Media Relations
DigiPath, Inc.
702-527-2060
Email >
Visit website